Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330 (7 May), doi:10.1136/bmj.330.7499.0-a
blocker
Combinations of statins, aspirins, and
blockers are associated with the greatest reduction in all cause mortality in patients with a first diagnosis of ischaemic heart disease. In a case-control analysis including 13 029 patients nested within an open prospective cohort study with 1.18 million patients, Hippisley-Cox and Coupland (p 1059) compared odds ratios for risk of death in patients with heart disease who were on different treatment regimens. The addition of an angiotensin converting enzyme inhibitor conferred no additional benefit despite adjusting the analyses for the presence of congestive heart failure.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses